Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

438
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
438
Drug Discovery: Overview01:26

Drug Discovery: Overview

12.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.3K
Cancer Therapies02:49

Cancer Therapies

10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Alcohol-associated hepatitis : 2025 update for the clinician].

Revue medicale suisse·2026
Same author

Risk Factors for Arterial Thromboembolic Events in Male Germ Cell Tumors Treated with Chemotherapy.

Cancers·2025
Same author

Primary and Acquired Resistance to Immunotherapy with Checkpoint Inhibitors in NSCLC: From Bedside to Bench and Back.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2025
Same author

[Metabolic steatotic liver disease: the move towards an inclusive definition].

Revue medicale suisse·2024
Same author

[Hypercalcemia: a practical review].

Revue medicale suisse·2024
Same author

[Thiazid diuretics : some useful considerations in clinical practice].

Revue medicale suisse·2024
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
Same journal

[Integrative medicine : a structured referral framework for general practitioners].

Revue medicale suisse·2026
Same journal

[Targeted therapy for ultra-rare diseases].

Revue medicale suisse·2026
Same journal

[Inherited metabolic diseases in adults : from diagnosis to treatment].

Revue medicale suisse·2026
Same journal

[Cardiogenetics in clinical practice : challenges, indications, and perspectives].

Revue medicale suisse·2026
Same journal

[Genetic medicine illustrated by three key syndromes].

Revue medicale suisse·2026
See all related articles

Related Experiment Video

Updated: Feb 27, 2026

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

2.0K

[New therapeutics].

Adriana Iacob Popescu1, Liz Coronado1, Aikaterini Efstathopoulou1

  • 1Service de médecine interne, Hôpital du Valais, Hôpital de Sion, Av. du Grand-Champsec 80, 1951 Sion.

Revue Medicale Suisse
|July 5, 2017
PubMed
Summary
This summary is machine-generated.

Physicians must stay updated on drug interactions and treatments. This summary covers quinolones, morphine, evolocumab, statins, vitamin D, and dexamethasone for better patient care.

More Related Videos

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

656
Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.5K

Related Experiment Videos

Last Updated: Feb 27, 2026

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

2.0K
Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

656
Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.5K

Area of Science:

  • Internal Medicine
  • Clinical Pharmacology
  • Evidence-Based Medicine

Background:

  • Daily medical practice requires continuous adaptation of drug use to new knowledge.
  • Physician assistants and residents must stay informed about recent clinical treatments.

Purpose of the Study:

  • To summarize six recent clinical treatments relevant to primary care and internal medicine.
  • To highlight key findings and considerations for commonly used medications and therapies.

Main Methods:

  • Review of recently published clinical studies and treatment guidelines.
  • Focus on six specific areas: quinolones, morphine and ticagrelor, evolocumab, statins and vaccines, vitamin D, and dexamethasone.

Main Results:

  • Quinolones are associated with QT interval widening.
  • Morphine can delay and attenuate ticagrelor action in myocardial infarction patients.
  • Evolocumab reduces lipids and cardiovascular events.
  • Statins may impact influenza vaccine effectiveness.
  • Vitamin D may prevent functional decline.
  • High-dose dexamethasone is used for immune thrombocytopenia.

Conclusions:

  • Physicians need to be aware of potential drug interactions and specific treatment impacts.
  • Staying updated on these six areas can improve patient outcomes and medication safety.